Device type · DRX
Electrode, Electrocardiograph
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DRX
Cardiovascular
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
425
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Electrode, Electrocardiograph
- Product code
- DRX
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2360
- Specialty
- Cardiology, Electrophysiology
- FDA record
- Classification database entry for DRX
Latest FDA decisions
- Physiotrace510(k)
K171244 · Decided Aug 23, 2017 · 117 days after receipt
Device type: Electrode, Electrocardiograph (DRX) · Cardiology
Reports received
425
Received Nov 1, 2025 to Nov 19, 2026. Includes 3 of another or unstated type.
Malfunction reports
90
21% of reports
Injury reports
331
78% of reports
Death reports
1
0.2% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 2 | 0 | 0 |
| Jan 24 | 2 | 4 | 0 | 0 |
| Feb 24 | 11 | 3 | 0 | 0 |
| Mar 24 | 3 | 4 | 1 | 0 |
| Apr 24 | 2 | 3 | 0 | 0 |
| May 24 | 2 | 8 | 0 | 1 |
| Jun 24 | 2 | 5 | 0 | 0 |
| Jul 24 | 2 | 0 | 0 | 0 |
| Aug 24 | 1 | 1 | 0 | 0 |
| Sep 24 | 2 | 0 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 | 0 |
| Nov 24 | 2 | 0 | 0 | 0 |
| Dec 24 | 0 | 1 | 0 | 0 |
| Jan 25 | 1 | 6 | 0 | 0 |
| Feb 25 | 6 | 1 | 0 | 0 |
| Mar 25 | 5 | 2 | 0 | 0 |
| Apr 25 | 9 | 3 | 0 | 0 |
| May 25 | 1 | 5 | 0 | 0 |
| Jun 25 | 4 | 13 | 0 | 0 |
| Jul 25 | 1 | 34 | 0 | 1 |
| Aug 25 | 1 | 13 | 0 | 0 |
| Sep 25 | 4 | 35 | 0 | 0 |
| Oct 25 | 3 | 35 | 0 | 0 |
| Nov 25 | 0 | 29 | 0 | 0 |
| Dec 25 | 1 | 37 | 0 | 0 |
| Jan 26 | 2 | 28 | 0 | 0 |
| Feb 26 | 5 | 27 | 0 | 0 |
| Mar 26 | 2 | 31 | 0 | 0 |
| Apr 26 | 1 | 23 | 0 | 0 |
| May 26 | 1 | 28 | 0 | 0 |
| Jun 26 | 1 | 20 | 0 | 0 |
| Jul 26 | 0 | 25 | 0 | 0 |
| Aug 26 | 1 | 21 | 1 | 1 |
| Sep 26 | 65 | 44 | 0 | 1 |
| Oct 26 | 11 | 18 | 0 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Biocompatibility177
- Adverse Event Without Identified Device or Use Problem146
- Loss of or Failure to Bond36
- Adhesive Too Strong10
- Insufficient Device Problem Information10
- Patient Device Interaction Problem5
- Communication or Transmission Problem3
- Device Dislodged or Dislocated3
- Patient-Device Incompatibility3
- Connection Problem2
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Skin Inflammation/ Irritation303
- No Clinical Signs, Symptoms or Conditions71
- Blister68
- Itching Sensation68
- Rash53
- Burning Sensation46
- Erythema45
- Burn(s)10
- Hypersensitivity/Allergic reaction8
- Skin Tears7
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Graphic Controls Acquisition Corporation
Z-0935-2022 · Started Mar 15, 2022
Reason given: Instructions for Use (IFU) (Instructions for Use) indicate compliance with ANSI/AAMI EC53:2013/(R)2020 ECG trunk cables and patient leadwires. Section 5.3.9 of the standard requires the device to withstand, without breakdown , an application of, 5,000 V d.c. when used with a defibrillator at a voltage above its...
Cause as FDA categorized it: Device Design
Graphic Controls Acquisition Corporation
Z-0936-2022 · Started Mar 15, 2022
Reason given: Instructions for Use (IFU) (Instructions for Use) indicate compliance with ANSI/AAMI EC53:2013/(R)2020 ECG trunk cables and patient leadwires. Section 5.3.9 of the standard requires the device to withstand, without breakdown , an application of, 5,000 V d.c. when used with a defibrillator at a voltage above its...
Cause as FDA categorized it: Device Design
Graphic Controls Acquisition Corporation
Z-0937-2022 · Started Mar 15, 2022
Reason given: Instructions for Use (IFU) (Instructions for Use) indicate compliance with ANSI/AAMI EC53:2013/(R)2020 ECG trunk cables and patient leadwires. Section 5.3.9 of the standard requires the device to withstand, without breakdown , an application of, 5,000 V d.c. when used with a defibrillator at a voltage above its...
Cause as FDA categorized it: Device Design
Graphic Controls Acquisition Corporation
Z-0938-2022 · Started Mar 15, 2022
Reason given: Instructions for Use (IFU) (Instructions for Use) indicate compliance with ANSI/AAMI EC53:2013/(R)2020 ECG trunk cables and patient leadwires. Section 5.3.9 of the standard requires the device to withstand, without breakdown , an application of, 5,000 V d.c. when used with a defibrillator at a voltage above its...
Cause as FDA categorized it: Device Design
Graphic Controls Acquisition Corporation
Z-0939-2022 · Started Mar 15, 2022
Reason given: Instructions for Use (IFU) (Instructions for Use) indicate compliance with ANSI/AAMI EC53:2013/(R)2020 ECG trunk cables and patient leadwires. Section 5.3.9 of the standard requires the device to withstand, without breakdown , an application of, 5,000 V d.c. when used with a defibrillator at a voltage above its...
Cause as FDA categorized it: Device Design
Graphic Controls Acquisition Corporation
Z-0940-2022 · Started Mar 15, 2022
Reason given: Instructions for Use (IFU) (Instructions for Use) indicate compliance with ANSI/AAMI EC53:2013/(R)2020 ECG trunk cables and patient leadwires. Section 5.3.9 of the standard requires the device to withstand, without breakdown , an application of, 5,000 V d.c. when used with a defibrillator at a voltage above its...
Cause as FDA categorized it: Device Design
3M Company - Health Care Business
Z-0188-2022 · Started Oct 6, 2021
Reason given: Potential for breakage of the ECG electrode carbon stud from the eyelet.
Cause as FDA categorized it: Process control
3M Company - Health Care Business
Z-0419-2021 · Started Sep 15, 2020
Reason given: Corrosion could cause performance failures in the product.
Cause as FDA categorized it: Process control
Showing the 8 newest of 20 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.